Dr. Hella Bolck
Dr. Hella Bolck
ZHAW
School of Engineering
Machine Perception & Cognition Group
Technikumstrasse 71
8400 Winterthur
Arbeit an der ZHAW
Tätigkeit
- Wissenschaftlerin im akademischen "Third Space"
- Research- and Project Manager
Arbeits- und Forschungsschwerpunkte
- Management komplexer Projekte
- Forschung ermöglichen im akademischen "Third Space"
- Anwendung von künstlicher Intelligenz für Analyse von biologischen und medizinischen Bildern und Daten
Berufserfahrung
- Senior Research Scientist
UniversitätsSpital Zürich
05 / 2018 - 01 / 2024 - Wissenschaftlerin (Postdoc)
UniversitätsSpital Zürich
04 / 2016 - 04 / 2018 - Wissenschaftlerin (Doktorat)
Universität Zürich
09 / 2011 - 04 / 2016
Aus- und Weiterbildung
Ausbildung
- Doktorat / Tumor Biologie
Universität Zürich
09 / 2011 - 04 / 2016 - Diplom / Biochemie und Molekularbiologie
Friedrich-Schiller Universität Jena
10 / 2005 - 08 / 2011
Netzwerk
ORCID digital identifier
Social Media
Projekte
- AI for REAL-world NETwork operation / Teammitglied / laufend
- LINA: Shared Large-scale Infrastructure for the Development and Safe Testing of Autonomous Systems / Stellv. Projektleiter:in / laufend
Publikationen vor Tätigkeit an der ZHAW
- SuperCUT, an unsupervised multimodal image registration with deep learning for biomedical microscopy. Brief. Bioinformatics (2024)
- Genomic alterations and diagnosis of renal cancer. Virchows Archiv (Nov. 2023)
- Ex vivo drug testing of patient‐derived papillary renal cancer cells reveals EGFR and the BCL2 family as therapeutic targets. Eur Urol Focus (Mar. 2023)
- RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor. Cells (Feb. 2022)
- SF3B1 facilitates HIF1‐signaling and promotes malignancy in pancreatic cancer. Cell Rep (Aug. 2022)
- Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease. Front Oncol (Oct. 2020)
- Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine. Front Cell Dev Biol (Oct. 2019)
- Tracing Clonal Dynamics Reveals that Two‐ and Three‐dimensional Patient‐derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma. Eur Urol Focus (Jun. 2019)
- Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear‐cell renal cell carcinoma. J Lipid Res (Nov. 2018)
- CtIP‐Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress. Mol Cell (Oct. 2018)
- FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep (May 2014)
- Targeting DNA double‐strand break signalling and repair: recent advances in cancer therapy. Swiss Med Wkly (Jul. 2013)
- Breakdown of the FLT3‐ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3‐ specific inhibitors. Mol Cancer Ther (Sept 2012)